Study participants “demonstrated significantly improved performance on measures of executive function relative to baseline, evidenced by faster response time[s] … as well as higher accuracy.”
Topic: CBD
Following treatment, two-thirds of the cohort exhibited a greater than 50 percent reduction in seizure frequency.
“These findings suggest that cannabidiol may benefit blood pressure control, specifically with prolonged use in hypertensive patients,” the study’s authors concluded.
“The findings support the use of topical CBD as a well-tolerated, non-invasive adjunct in the multimodal management of temporomandibular disorders,” investigators determined.
“Blinded clinical impressions showed almost two-third of the participants had behavioral improvements with CBD,” researchers reported.
“Both cannabis and CBD users reported high effectiveness levels for sleep disorders, pain, and rigidity,” investigators reported.
“The findings of this study indicate that CBD reduces inflammatory response in the brain and improves cognitive decline associated with aging.”
Following the daily use of cannabis extracts, all patients experienced seizure freedom for periods of at least 90 days.